StockData
Contineum Therapeutics, Inc. logo

Contineum Therapeutics, Inc. (CTNM) stock

CTNMNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 8/30
$9.55−0.12 (-1.24%)

Close on Nov 17, 2026Market cap $359.28MP/E –Yield –

Contineum Therapeutics profit margin

Profit margin (net margin) is net income as a percentage of revenue.

Contineum Therapeutics's profit margin for the twelve months ending Dec 31, 2023 was 45.4%. For fiscal 2023 it was 45.4%.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2023Dec 31, 202345.4%–

Quarterly profit margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2023Jun 30, 202383.1%–

More Contineum Therapeutics figures

See a number that looks wrong?